Core Points - Abacus Global Management, Inc. has completed its exchange offer and consent solicitation for outstanding public and private placement warrants, resulting in the issuance of 4,183,160 shares of common stock [1][2] - The company has amended the warrant agreement to exchange each outstanding warrant for 0.207 shares of common stock, which is 10% less than the initial exchange ratio [2] - Following the completion of the offer and post-offer exchange, all warrants will be eliminated, and public warrants will be delisted from Nasdaq on August 14, 2025 [3] Company Overview - Abacus Global Management specializes in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services [5] - The company focuses on longevity-based assets and personalized financial planning, utilizing proprietary data analytics and industry expertise to enhance financial outcomes for clients [5]

Core Points - Abacus Global Management, Inc. announced the expiration and results of its exchange offer and consent solicitation for outstanding public and private placement warrants [1][2] - Approximately 88% of the outstanding warrants were validly tendered, and the company expects to accept all validly tendered warrants for exchange [2] - The company received approval from parties representing approximately 83% of the outstanding public warrants and 94% of the outstanding private placement warrants for a warrant agreement amendment [2] - The exchange ratio for the post-offer exchange will be 0.207 shares of common stock per warrant, which is 10% less than the initial exchange ratio [2] Company Overview - Abacus Global Management specializes in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services [6] - The company focuses on longevity-based assets and personalized financial planning, leveraging proprietary data analytics and industry expertise [6] Regulatory Information - A registration statement on Form S-4 for the common stock issuable in the offer was declared effective by the SEC on July 28, 2025 [5]

Core Viewpoint - Wolf Popper LLP is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. common stock following allegations of accounting irregularities and related party dealings that have led to a significant decline in stock price [1][2][3][4]. Group 1: Company Overview - Abacus Global Management, Inc. is an alternative asset manager specializing in life insurance products [1]. - The company was involved in a $618 million de-SPAC deal that closed on July 3, 2023 [1]. Group 2: Allegations and Reports - A short seller report by Morpheus Research alleged that Abacus engaged in accounting schemes to inflate revenue by underestimating life expectancy [2]. - The report raised concerns about Abacus' valuation methodology and the use of Lapetus Solutions for life expectancy calculations, which were questioned by former employees and industry experts [2]. - A second report from Morpheus Research claimed that Abacus did not adequately refute the allegations and pointed out undisclosed related party dealings by insiders [3]. Group 3: Stock Performance - Following the initial report, Abacus' stock price fell by $1.64 to $6.00 on June 4, 2025, representing a 21.5% decline [2]. - As of July 21, 2025, the stock price had decreased over 33% from the initial report, closing at $5.22 per share [4].

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices by Abacus Global Management, Inc. [1] Group 1: Investigation Details - The investigation is focused on whether Abacus and its officers or directors have engaged in fraudulent activities [1] - Investors are encouraged to contact Pomerantz LLP for more information regarding the investigation [1] Group 2: Allegations Against Abacus - A report by Morpheus Research claims that Abacus has manipulated its portfolio valuation methodology to present a misleadingly profitable image [3] - The report also criticizes Abacus's life expectancy estimation methods and highlights historical concerns regarding its co-founders [3] Group 3: Market Reaction - Following the release of the allegations, Abacus's stock price dropped by $1.64, or 21.47%, closing at $6.00 per share on June 5, 2025 [4]

Core Viewpoint - Abacus Life, Inc. is positioned to potentially continue its earnings-beat streak, supported by a strong earnings history and positive analyst sentiment [1][5]. Earnings Performance - For the most recent quarter, Abacus Life reported earnings of $0.16 per share, falling short of the expected $0.18, resulting in a surprise of 12.50% [2]. - In the previous quarter, the company exceeded expectations by reporting $0.16 per share against a consensus estimate of $0.13, achieving a surprise of 23.08% [2]. Analyst Sentiment - Recent estimates for Abacus Life have been increasing, with a positive Earnings ESP of +3.03%, indicating bullish sentiment among analysts regarding the company's earnings prospects [5][8]. - The combination of a positive Earnings ESP and a Zacks Rank of 2 (Buy) suggests a high likelihood of another earnings beat in the upcoming report [8]. Predictive Metrics - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have historically produced positive surprises nearly 70% of the time, indicating a strong predictive power for earnings performance [6]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [7].

Core Viewpoint - Abacus Global Management, Inc. is set to release its second quarter 2025 financial results on August 7, 2025, after market close, indicating ongoing transparency and communication with investors [1]. Group 1: Financial Results Announcement - The financial results for the second quarter of 2025 will be announced after market hours on August 7, 2025 [1]. - A conference call to discuss these results will take place at 5:00 pm Eastern Time on the same day [2]. - Investors can access a live webcast of the conference call on the company's investor relations website [2]. Group 2: Company Overview - Abacus Global Management is a prominent player in the alternative asset management sector, focusing on data-driven wealth solutions and technology innovations [3]. - The company specializes in longevity-based assets and personalized financial planning, utilizing proprietary data analytics to enhance financial outcomes for clients [3].

Core Viewpoint - Abacus Global Management, Inc. is under investigation for potential securities fraud and unlawful business practices, following allegations of manipulating financial reporting to appear more profitable than it is [1][2]. Group 1: Investigation and Allegations - An investigation is being conducted on behalf of investors of Abacus Global Management regarding possible securities fraud by the company and its officers or directors [1]. - A report by Morpheus Research claims that Abacus has altered its portfolio valuation methodology to inflate profitability and uses questionable life expectancy calculations, raising concerns about the integrity of its financial practices [2]. Group 2: Market Reaction - Following the news of the investigation and the allegations, Abacus's stock price experienced a significant decline, falling by $1.64 per share, or 21.47%, closing at $6.00 per share on June 5, 2025 [3].

Core Viewpoint - Abacus Global Management, Inc. has filed a lawsuit against Coventry First LLC and its Chairman Alan Buerger, alleging a systematic campaign to disseminate false and misleading information aimed at damaging Abacus's reputation and market position [1][2][3]. Group 1: Allegations and Lawsuit Details - The lawsuit claims that Coventry and Buerger engaged in a multi-year effort to undermine Abacus's valuation practices, attempting to convince the market that Abacus overpays policyholders, leading to an overvaluation of its assets [3][4]. - Abacus asserts that Coventry's actions constitute tortious interference and defamation, as they have resorted to damaging Abacus's reputation instead of competing fairly [4]. - The lawsuit highlights that Abacus's financial practices are transparent and compliant with GAAP, contradicting Coventry's claims about Abacus's valuation methods [8][9]. Group 2: Impact of False Claims - Following a June 4, 2025 interview with Buerger, Abacus's stock dropped over 21%, resulting in a loss of more than $200 million in market capitalization due to the dissemination of false information [9][10]. - Abacus alleges that Coventry's campaign has caused substantial harm to its reputation, customer base, and investor relationships, with the company seeking hundreds of millions in damages [11][12]. - The lawsuit also points out that Coventry has a history of unsavory practices, including bid-rigging and involvement in illegal life insurance practices, which further undermines its credibility [11][12]. Group 3: Role of Short Seller - Morpheus Research is identified as a partner in disseminating Coventry's defamatory statements, with the short report released shortly after Buerger's interview, amplifying the false claims about Abacus [10][11]. - The lawsuit alleges that Morpheus's report echoed Coventry's misleading statements, contributing to the confusion among investors and market analysts [10][11].

Core Viewpoint - Abacus Global Management, Inc. has initiated an exchange offer and consent solicitation to simplify its capital structure and mitigate the potential dilutive impact of outstanding warrants [1][2]. Group 1: Exchange Offer Details - The company is offering 0.23 shares of common stock for each warrant tendered, with a total of up to 4,743,381 shares available for exchange [2]. - The offering period will last until July 29, 2025, with the possibility of extension [2]. - Holders can withdraw their tendered warrants at any time before the expiration date [2]. Group 2: Consent Solicitation - The company is soliciting consents to amend the warrant agreement, allowing for an exchange ratio of 0.207 shares per warrant, which is 10% less than the current offer [3]. - Approximately 25% of public warrants and 94% of private placement warrants have agreed to participate in the offer and consent to the amendment [3]. - An additional 25% consent from public warrant holders is needed for the amendment to be adopted [3]. Group 3: Current Capital Structure - As of June 30, 2025, there are 97,867,821 shares of common stock and 20,623,395 warrants outstanding [5]. - If all warrants are exchanged, the total shares outstanding would increase to 102,611,202, representing a 5% increase, with no warrants remaining [5]. Group 4: Regulatory Information - The offer and consent solicitation are conducted under a prospectus and Schedule TO filed with the SEC [4]. - D.F. King & Co., Inc. is the information agent, while Continental Stock Transfer & Trust Company serves as the exchange agent [6].

Core Viewpoint - Abacus Global Management, Inc. plans to conduct an exchange offer and consent solicitation for its outstanding public and private placement warrants, allowing holders to exchange warrants for shares of common stock [1][2]. Group 1: Exchange Offer Details - Each outstanding warrant is exercisable for one common share at a price of $11.50 per share [2]. - The company intends to offer 0.23 shares of common stock in exchange for each outstanding warrant tendered [2]. - The company will also solicit consents to amend the Warrant Agreement, allowing for an exchange ratio of 0.207 shares per warrant, which is 10% less than the initial offer [2]. Group 2: Regulatory and Procedural Aspects - The company expects to commence the Offer after filing a Form S-4 registration statement detailing the terms of the Offer [3].